| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/12/2003 | EP1282617A1 Hydantoin derivatives with affinity for somatostatin receptors |
| 02/12/2003 | EP1282616A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 02/12/2003 | EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders |
| 02/12/2003 | EP1282435A2 Interleukin-1 inhibitors in the treatment of diseases |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282414A2 Felbamate derived compounds |
| 02/12/2003 | EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282408A1 Hydrogel composition for transdermal drug delivery |
| 02/12/2003 | EP1282403A1 Non-invasive gene targeting to the brain |
| 02/12/2003 | EP1282366A2 Compositions containing folic acid and reduced folate |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP1109534B1 Quick release pharmaceutical compositions of drug substances |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP1049703B1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme |
| 02/12/2003 | EP1032566B1 Method for the preparation of citalopram |
| 02/12/2003 | EP1019088B1 Composition for the treatment of nicotine addiction containing mecamylamine and bupropion |
| 02/12/2003 | EP1003542B1 Use of substances having oxytocin activity for preparation of medicaments for wound healing |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | EP0941112B1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0711154B1 Stabilized pharmaceutical composition containing bupropion |
| 02/12/2003 | EP0669920B1 Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| 02/12/2003 | CN1396926A Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396921A Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 02/12/2003 | CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396910A Use of vitamin D-derivatives in treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396829A New drug combinations |
| 02/12/2003 | CN1396826A Use of pramipexole for treatment of addictive disorders |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396183A Human fusion antibody for reducing cerebral amyloid fibers associated with senile dementia |
| 02/12/2003 | CN1395965A Nutritive refreshing medicine 'Haizhen' |
| 02/12/2003 | CN1395956A Chinese medicine for treating depression and anxiety |
| 02/12/2003 | CN1395931A Oral-applied slow-releasing or release-controllable solid clozapine |
| 02/12/2003 | CN1395930A Slow-releasing maclobemide tablet |
| 02/12/2003 | CN1395929A Slow-releasing maclobemide capsule |
| 02/12/2003 | CN1395925A Slow-releasing Anixitan tablet |
| 02/12/2003 | CN1395924A Slow-releasing Anixidan capsule |
| 02/12/2003 | CN1101382C Derivatives of 10,11-dihydro-10-oxo-5H-dibenz/b.f/azepine-5-carboxamide |
| 02/12/2003 | CN1101224C Injection for giving up addiction |
| 02/12/2003 | CN1101210C Health-preserving capsule |
| 02/12/2003 | CN1101203C Pain-relieving arthralgia dredging Chinese medicine preparation |
| 02/12/2003 | CN1101187C Fluoxetine pharmaceutial formulations |
| 02/11/2003 | US6518422 Hydrogenation of 5,5-dioxo-2,3-dihydro-1H-pyrrolo-(2,1-c)(1,2,4)benzothiadiazine with a complex of ruthenium dichloride with 2,2'-bis(diphenylphosphine)-1,1'-binaphthyl and 1,2-diphenylethylenediamine as catalyst |
| 02/11/2003 | US6518421 Process for the preparation of epothilone analogs |
| 02/11/2003 | US6518319 Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms |
| 02/11/2003 | US6518316 Cytokine production and tyrosine kinase inhibitors |
| 02/11/2003 | US6518314 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions |
| 02/11/2003 | US6518311 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 02/11/2003 | US6518303 Selectively inhibit COX-2 in preference to COX-1 and are useful in the treatment of COX-2 mediated diseases, such as inflammation, pain, fever and asthma with fewer side effects |
| 02/11/2003 | US6518301 Better selectivity than estrogen for the estrogen receptor-beta over receptor-alpha; treatment of Alzheimer's disease, anxiety, depression, osteoporosis, cardiovascular disease, rheumatoid arthritis, or prostate cancer |
| 02/11/2003 | US6518295 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/11/2003 | US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518273 2-aryl indole derivative as antagonists of tachykinins |
| 02/11/2003 | US6518271 1H-imidazo[4,5-d]pyridazin-7-one, and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | US6518260 (α-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof |
| 02/11/2003 | US6518258 6-sulphamoyl -3-quinolyphosphonic acid compounds |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518238 Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
| 02/11/2003 | US6518235 Methods for improving brain function using leptin or analogs thereof |
| 02/11/2003 | US6518031 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/11/2003 | US6518010 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 02/11/2003 | US6517866 Sertraline salts and sustained-release dosage forms of sertraline |
| 02/11/2003 | US6517859 Injectable, drug delivery vehicles; controlled release of bioactive agents to sites within the central nervous system; dopamine, cholecystokinin, and epidermal and basic fibroblast growth factors for Parkinson's disease |
| 02/11/2003 | US6517810 Palliation of bone pain due to cancer by the administration of a tin stannic (Sn+4) chelate complex |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2141554C Morphogen-induced nerve regeneration and repair |
| 02/11/2003 | CA2102606C Compositions for the treatment of chronic fatigue syndrome |
| 02/11/2003 | CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region |
| 02/11/2003 | CA2078670C Compositions and methods for treatment of acne vulgaris and retardation of ageing |
| 02/11/2003 | CA2047237C Chroman derivatives |
| 02/11/2003 | CA2043229C Pyrido[3,4-b]pyrrolo[1,2-e] [1,4,5]oxadiazepines and related analogs, a process for their preparation and their use as medicaments |
| 02/11/2003 | CA2041818C Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers |
| 02/11/2003 | CA2030715C Hexahydro-1h-quino¬4,3,2-ef|¬1,4|benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments |
| 02/07/2003 | CA2354743A1 Mitochondrially targeted antioxidants |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |
| 02/06/2003 | WO2003010297A1 Probiotic bifidobacterium strains |
| 02/06/2003 | WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/06/2003 | WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | WO2003010243A2 Multipotent stem cells from peripheral tissues and uses thereof |
| 02/06/2003 | WO2003010196A2 Variants and exons of the glyt1 transporter |
| 02/06/2003 | WO2003010169A1 Antidepressant azaheterocyclylmethyl derivatives of 7, 8-dihydro-6h-5-oxa-1-aza-phenanthrene |
| 02/06/2003 | WO2003010168A1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 02/06/2003 | WO2003010167A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 02/06/2003 | WO2003010166A1 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 02/06/2003 | WO2003010164A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/06/2003 | WO2003010161A1 S-6-hydroxy-buspirone |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003010158A1 Novel compounds |